Search

Search Constraints

You searched for: Author/Creator Knopman, David S.

Search Results

402. P4‐288: DETAILS OF THE NEW ALZHEIMER'S ASSOCIATION BEST CLINICAL PRACTICE GUIDELINES FOR THE EVALUATION OF NEURODEGENERATIVE COGNITIVE BEHAVIORAL SYNDROMES, ALZHEIMER'S DISEASE AND DEMENTIAS IN THE UNITED STATES. (1st July 2006)

403. P4‐303: DISCOVERING SOURCES OF VARIABILITY IN AMYLOID DEPOSITION USING DATA‐DRIVEN ANALYSES. (1st July 2019)

404. P4‐318: PET MEASUREMENTS OF PHF TAU BURDEN IN COGNITIVELY UNIMPAIRED PERSONS WITH TWO, ONE AND NO COPIES OF THE APOE4 ALLELE. (1st July 2006)

405. P4‐319: CLINICAL FEATURES, CSF BIOMARKERS, MOLECULAR IMAGING, AND PATHOLOGY IN DYSEXECUTIVE ALZHEIMER'S DISEASE. (1st July 2006)

407. P4‐537: DETECTION OF ALZHEIMER'S DISEASE IN CSF USING AUTOMATED ASSAYS FOR CLASSICAL CSF BIOMARKERS. (1st July 2019)

408. Performance of the CogState computerized battery in the Mayo Clinic Study on Aging. Issue 11 (6th April 2015)

409. Phenoconversion from probable rapid eye movement sleep behavior disorder to mild cognitive impairment to dementia in a population‐based sample. Issue 1 (30th May 2017)

410. Plasma amyloid β levels are driven by genetic variants near APOE, BACE1, APP, PSEN2: A genome‐wide association study in over 12, 000 non‐demented participants. Issue 10 (18th May 2021)